Autoimmune hepatitis revealed by atorvastatin
- 1 August 2003
- journal article
- case report
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 15 (8) , 921-924
- https://doi.org/10.1097/00042737-200308000-00014
Abstract
Cases of acute hepatitis induced by statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have been reported. A 65-year-old woman was admitted to our hospital because of fatigue, jaundice and altered liver function tests while on treatment with atorvastatin. On the basis of clinical, serological and histological findings, a score leading to a diagnosis of autoimmune hepatitis was reached. We suggest that atorvastatin may have revealed an underlying autoimmune hepatitis.Keywords
This publication has 7 references indexed in Scilit:
- HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statinsExperimental and Toxicologic Pathology, 2000
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Cholestatic liver dysfunctionThe Lancet, 1999
- Genetic Heterogeneity in Susceptibility To Autoimmune Hepatitis Types 1 and 2American Journal of Gastroenterology, 1999
- Ator vastatin-induced acute hepatitis with absence of cross-toxicity with simvastatinThe Lancet, 1999
- Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment GoalsThe American Journal of Cardiology, 1997
- AtorvastatinDrugs, 1997